PT  - JOURNAL ARTICLE
ED - BMJ Publishing Group Ltd
TI  - Oxpentifylline (trental) in peripheral arterial disease
AID  - 10.1136/dtb.14.15.59
DP  - 1976 Jul 16
TA  - Drug and Therapeutics Bulletin
PG  - 59--60
VI  - 14
IP  - 15
4099  - http://dtb.bmj.com/content/14/15/59.short
4100  - http://dtb.bmj.com/content/14/15/59.full
SO  - Drug Ther Bull1976 Jul 16; 14
AB  - Vasodilators are disappointing in the treatment of peripheral vascular disease. There is little evidence that they either increase blood flow or improve symptoms.1 Oxpentifylline (Trental - Hoechst) is a dimethyl xanthine related to caffeine, theobromine and theophylline. It is a weak vasodilator, but the maker claims that it also reduces blood viscosity which is increased in patients with peripheral vascular disease.2 3